Kinetics of Tetracaine Solvolysis in Propylene Glycol
Author(s): McPherson Timothy B, Neumann William L, Goolsby Michael, Kolling William M
Issue: Jul/Aug 2018 - Volume 22, Number 4
View All Articles in Issue
Page(s): 329-334
Download in electronic PDF format for $75
Abstract: Tetracaine is a potent ester-type local anesthetic. Recent publications describe the use of TC free base in topical anesthetic formulations containing propylene glycol. While solvolysis of tetracaine in propylene glycol solutions has been reported, there are no detailed reports on the kinetics of tetracaine reaction with propylene glycol. The objectives of the study were to characterize the kinetics and temperature dependence of tetracaine solvolysis in PG solutions. In this study, products of tetracaine degradation in propylene glycol solution at 60ÅãC were collected and analyzed by high-performance liquid chromatographymass spectrometry and nuclear magnetic resonance. The kinetics of tetracaine reaction with propylene glycol was studied at 22ÅãC, 30ÅãC, 40ÅãC, and 60ÅãC. The reaction of tetracaine with n-propanol and isopropanol was also studied. Analysis was performed by high-performance liquid chromatography-mass spectrometry with ultraviolet detection using a gradient elution method. Tetracaine concentrations were quantitated using a four-point standard curve. Tetracaine degradation rates were consistent with apparent first order kinetics at all temperatures studied. The data indicated that tetracaine degrades via transesterification with propylene glycol. The rate constants ranged from 2.26 Å~ 10-3 d-1 at 22ÅãC to 7.06 Å~ 10-2 d-1 at 60ÅãC. Arrhenius analysis indicated an activation energy for the reaction of 74.1 kJ/mol, which is similar to published values for the hydrolysis of pharmaceutical esters.
Related Keywords:
Timothy B. McPherson, PhD, William L. Neumann, PhD, Michael Goolsby, PharmD, William M. Kolling, PhD, tetracaine, ester-type local anesthetic, topical preparation, solvolysis, propylene glycol, degradation kinetics, temperature
Related Categories:
ENVIRONMENTAL , PAIN MANAGEMENT, PEER-REVIEWED, STABILITIES, COMPATIBILITIES
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Kinetics of Tetracaine Solvolysis in Propylene Glycol
McPherson Timothy B, Neumann William L, Goolsby Michael, Kolling William M
|
Jul/Aug 2018
Pg. 329-334
|
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson Timothy B, Neumann William L, Kolling William M
|
Nov/Dec 2013
Pg. 508-511
|
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
|
Nov/Dec 2004
Pg. 458-460
|
Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 414
|
Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 64
|
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
|
May/Jun 2015
Pg. 261-267
|
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
Tetracaine 4% and Menthol 5% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 73
|
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 50
|
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 133
|
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 513
|
Compounded Local Anesthetics to Minimize Pain from Medical Procedures
McElhiney Linda F
|
May/Jun 2008
Pg. 192-197
|
Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G, Pepin Steven M
|
May/Jun 2009
Pg. 218-219
|
Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G, Pepin Steven M
|
Mar/Apr 2024
Pg. 118-119
|
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
|
Sep/Oct 2012
Pg. 431-433
|
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
|
Mar/Apr 2022
Pg. 150-154
|
Potassium Nitrate/Benzocaine/Tetracaine Dental Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 266
|
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
|
Mar/Apr 2016
Pg. 148-154
|
Sorbitan Esters, Featured Excipient:
Allen Loyd V Jr
|
May/Jun 2002
Pg. 221-223
|
Tetracaine 0.025% Popsicles
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 73
|
Return to Top |